US18978H2013 - Common Stock
CNS Pharmaceuticals just reported results for the fourth quarter of 2023.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips CNS Pharmaceuticals (NASDAQ:CNSP) just reported results for the fourth quarter ...
We're starting off trading on Tuesday with a look into the biggest pre-market stock movers traders need to keep an eye on today!
CNS Pharmaceuticals announces public offering of 13.3 million shares at $0.30 per share, accompanied by Series A and Series B Warrants.
Read about CNS Pharmaceuticals' filing of a prospectus for the sale of 3.81M common stock.
CNS Pharmaceuticals (CNSP) files prospectus for the offer and resale of 3.76M shares of common stock, but it is not an offer to sell.
Moleculin (MBRX) said that it has retained analytics firm Shareholder Intelligence Services, or ShareIntel, to investigate possible naked short selling of its shares. Read more here.
/PRNewswire/ -- - The COVID-19 pandemic has had a limited impact on the global breast cancer therapeutics market and reports see substantial growth now that it...
EQNX::TICKER_START (NASDAQ:ONCY),(NASDAQ:GILD),(NASDAQ:RAIN),(NASDAQ:CNSP),(NYSE:BMY) EQNX::TICKER_END
We're starting off the week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday!